Metabolic Profiling of Human Plasma and Urine, Targeting Tryptophan, Tyrosine and Branched Chain Amino Acid Pathways

• Main Authors: Andrea Anesi, Josep Rubert, Kolade Oluwagbemigun, Ximena Orozco-Ruiz, Ute Nöthlings, Monique M.B. Breteler, Fulvio Mattivi
• Format: Article
• Language: English
• Published: MDPI AG 2019-11-01
• Series: Metabolites
• Subjects: tryptophan metabolism; tyrosine metabolism; branched chain amino acids; gut microbiota metabolites; targeted metabolomics; lc-ms/ms; human plasma; urine; clinical studies
• Online Access: https://www.mdpi.com/2218-1989/9/11/261

Tryptophan and tyrosine metabolism has a major effect on human health, and disorders have been associated with the development of several pathologies. Recently, gut microbial metabolism was found to be important for maintaining correct physiology. Here, we describe the development and validation of a UHPLC-ESI-MS/MS method for targeted quantification of 39 metabolites related to tryptophan and tyrosine metabolism, branched chain amino acids and gut-derived metabolites in human plasma and urine. Extraction from plasma was optimised using 96-well plates, shown to be effective in removing phospholipids. Urine was filtered and diluted ten-fold. Metabolites were separated with reverse phase chromatography and detected using triple quadrupole MS. Linear ranges (from ppb to ppm) and correlation coefficients (<i>r</i>² &gt; 0.990) were established for both matrices independently and the method was shown to be linear for all tested metabolites. At medium spiked concentration, recovery was over 80% in both matrices, while analytical precision was excellent (CV &lt; 15%). Matrix effects were minimal and retention time stability was excellent. The applicability of the methods was tested on biological samples, and metabolite concentrations were found to be in agreement with available data. The method allows the analysis of up to 96 samples per day and was demonstrated to be stable for up to three weeks from acquisition.